We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
(-5.5%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$25.2M |
| 2 |
Ashland
ASH
|
+$17.2M |
| 3 |
IBM
IBM
|
+$17.1M |
| 4 |
Madison Square Garden
MSGS
|
+$16.7M |
| 5 |
Valero Energy
VLO
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$35.9M |
| 2 |
Qualcomm
QCOM
|
+$29M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$27.5M |
| 4 |
Agilent Technologies
A
|
+$26.4M |
| 5 |
Northrop Grumman
NOC
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 19.14% |
| 3 | Healthcare | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRAY
376
DELISTED
Cray, Inc.
CRAY
| $2.52M | 0.05% |
137,169
+20,750
| +18% | +$382K |
|
377
Stride
LRN
$3.67B
| $2.52M | 0.05% |
140,789
+37,590
| +36% | +$721K |
|
|
SBNY
378
DELISTED
Signature Bank
SBNY
| $2.51M | 0.05% |
17,516
-730
| -4% | -$104K |
|
|
IMGN
379
DELISTED
Immunogen Inc
IMGN
| $2.49M | 0.05% |
+350,634
| New | +$1.6M |
|
380
Parker-Hannifin
PH
$126B
| $2.49M | 0.05% |
15,564
+4,494
| +41% | +$712K |
|
381
Koppers
KOP
$972M
| $2.48M | 0.05% |
68,625
+50,321
| +275% | +$1.94M |
|
|
SSNI
382
DELISTED
Silver Spring Networks, Inc.
SSNI
| $2.47M | 0.05% |
219,108
+4,310
| +2% | +$46.6K |
|
383
Varonis Systems
VRNS
$5.33B
| $2.46M | 0.05% |
198,480
+11,400
| +6% | +$131K |
|
|
PGRE
384
DELISTED
Paramount Group
PGRE
| $2.45M | 0.05% |
153,148
+40,515
| +36% | +$658K |
|
385
UMB Financial
UMBF
$10.8B
| $2.45M | 0.05% |
32,720
-800
| -2% | -$58.6K |
|
|
PNK
386
DELISTED
Pinnacle Entertainment Inc.
PNK
| $2.45M | 0.05% |
+123,900
| New | +$2.49M |
|
|
ALOG
387
DELISTED
Analogic Corp
ALOG
| $2.43M | 0.05% |
33,505
-3,646
| -10% | -$261K |
|
388
McDonald's
MCD
$189B
| $2.43M | 0.05% |
15,850
+2,020
| +15% | +$292K |
|
389
NCR Voyix
VYX
$1.06B
| $2.42M | 0.05% |
96,659
| – | – |
|
390
Moog Inc Class A
MOG.A
$13.1B
| $2.4M | 0.05% |
33,510
+50
| +0.1% | +$3.46K |
|
391
Atlantic Union Bankshares
AUB
$6.02B
| $2.4M | 0.05% |
+70,651
| New | +$2.41M |
|
|
SIGM
392
DELISTED
Sigma Designs Inc
SIGM
| $2.38M | 0.05% |
407,505
+57,800
| +17% | +$350K |
|
393
V2X
VVX
$2.63B
| $2.37M | 0.05% |
73,439
+33,940
| +86% | +$945K |
|
394
Diodes
DIOD
$4.06B
| $2.35M | 0.05% |
98,000
+47,300
| +93% | +$1.17M |
|
395
Prosperity Bancshares
PB
$8.79B
| $2.35M | 0.05% |
36,600
+8,000
| +28% | +$527K |
|
396
AngioDynamics
ANGO
$564M
| $2.33M | 0.05% |
144,014
-15,902
| -10% | -$251K |
|
|
TXNM
397
TXNM Energy Inc
TXNM
$6.46B
| $2.32M | 0.05% |
60,730
+18,000
| +42% | +$685K |
|
398
Kratos Defense & Security Solutions
KTOS
$9.01B
| $2.31M | 0.05% |
194,431
-18,800
| -9% | -$179K |
|
399
Comfort Systems
FIX
$62.7B
| $2.29M | 0.05% |
61,670
+39,300
| +176% | +$1.39M |
|
400
Hawaiian Electric Industries
HE
$2.33B
| $2.29M | 0.05% |
70,593
+41,100
| +139% | +$1.37M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2017 Portfolio in Review
As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.
- Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
- Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
- Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
- Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
- Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
- Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.